Must-Read Source for Pharmaceutical News


With the emergence of value-based care and technological advancements, pharma and biotech companies must work with healthcare providers, as well as regulators, payers, and patients on ensuring the availability and affordability of new and existing therapies for improved patient outcomes. 


The newsletter focuses on how the pharma and biotech industries are working to engage with healthcare providers and covers topics such as M&A activity, digital therapeutics, innovative technology, precision medicine, regulatory policy, drug pricing, clinical trials, and more. 



"The new vertical will provide in-depth analyses on the developments and trends impacting the pharmaceutical and biotechnology industries … as the lines that define all healthcare industry segments have been blurring."


Ana Mulero, pharma contributing editor